SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-070834
Filing Date
2022-11-10
Accepted
2022-11-10 08:16:04
Documents
46
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_cormedix.htm   iXBRL 10-Q 749299
2 CERTIFICATION f10q0922ex31-1_cormedix.htm EX-31.1 11472
3 CERTIFICATION f10q0922ex31-2_cormedix.htm EX-31.2 11438
4 CERTIFICATION f10q0922ex32-1_cormedix.htm EX-32.1 3864
5 CERTIFICATION f10q0922ex32-2_cormedix.htm EX-32.2 3897
  Complete submission text file 0001213900-22-070834.txt   3790928

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20220930.xsd EX-101.SCH 34538
7 XBRL CALCULATION FILE crmd-20220930_cal.xml EX-101.CAL 29770
8 XBRL DEFINITION FILE crmd-20220930_def.xml EX-101.DEF 168802
9 XBRL LABEL FILE crmd-20220930_lab.xml EX-101.LAB 348145
10 XBRL PRESENTATION FILE crmd-20220930_pre.xml EX-101.PRE 179645
40 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_cormedix_htm.xml XML 469244
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 221375074
SIC: 2834 Pharmaceutical Preparations